Winning entry in art competition depictsbeauty, wholeness despite mastectomy

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 12
Volume 17
Issue 12

Architect Nikko Shabtai, of Beverly Hills, Calif., took fi rst prize in the Oncology on Canvas event, sponsored by Eli Lilly in partnership with the National Coalition for Cancer Survivorship.

Architect Nikko Shabtai, of Beverly Hills, Calif., took first prize in the Oncology on Canvas event, sponsored by Eli Lilly in partnership with the National Coalition for Cancer Survivorship.

Mr. Shabtai used a painter’s knife, rather than a paintbrush, to create “As I Am, Beautiful and Whole,” which won the Best of Exhibition trophy and an award of $10,000 donated to the Cancer Schmancer Foundation on his behalf.

Mr. Shabtai’s acrylic painting portrays a woman who appears to have undergone a mastectomy. “I was painting the model in my painting workshop when I picked up my knife instead of a brush and painted her without a breast,” Mr. Shabtai explained in a written statement. He said he realized that his inspiration for this piece was the breast cancer diagnosis, and subsequent mastectomy, that a family member had recently experienced.

 

In all, 19 winners were selected in the Oncology on Canvas: Expressions of a Cancer Journey Art Competition and Exhibition, with 26 prizes given to 22 cancer charities.

Elizabeth Menges of Boston took home second prize for a series of six small oil paintings that detail the morning dressing routine of a breast cancer survivor.

New York-based breast cancer survivor Barbara E. Litke and artist Nash Hyon, of Wilton, Conn., tied for third place.

 

 

 

 

 

 

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Surgery and radiation chemotherapy can affect immunotherapy’s ability to target tumor cells in the nervous system, according to John Henson, MD.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Related Content